methylprednisolone hemisuccinate has been researched along with betamethasone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barenholz, Y; Baru, M; Harel, M; Katzavian, G; Naparstek, Y; Sigal, A; Turjeman, K; Ulmansky, R | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and betamethasone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Glucocorticoids in nano-liposomes administered intravenously and subcutaneously to adjuvant arthritis rats are superior to the free drugs in suppressing arthritis and inflammatory cytokines.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Betamethasone; Cells, Cultured; Cytokines; Drug Administration Schedule; Drug Carriers; Female; Glucocorticoids; Injections, Intravenous; Injections, Subcutaneous; Liposomes; Methylprednisolone Hemisuccinate; Mice; Mice, Inbred Strains; Nanoparticles; Rats; Rats, Inbred Lew; Spleen; Treatment Outcome | 2012 |